Yeah, I don't trust Amos either.
I stand by my previous statement of CF+ by 2026/2027. Why? The fact the company hasn't released the GTV figures for Q2, so there's no way of knowing just how much revenue they'll pull in over the next 1 - 12 months. I find it hard to believe the APAI product will pull in $1.5M during the initial rollout.
I think dilution & consolidations are in the works here.
All eyes on Q3 report.
Ann: Investor Presentation, page-41
Add W2V (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.230M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.8¢ | $67.37K | 7.464M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 16143916 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2195261 | 4 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| W2V (ASX) Chart |